Pseudomonas Superbug Develops Fast Resistance to ‘Last Resort’ Antibiotic
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a "last resort" antibiotic.
Tag: bacterial lung infection
All
Latest
All
Latest
Trial to Test Dalbavancin as Treatment for S. aureus
NIH will conduct a clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia.
All
Latest
Scientists Build Micro-device to Detect Viruses
Engineering researchers developed a device that uses magnetic nano-beads to isolate minute particles that cause diseases. The new research is published in in the journal ACS Applied Materials and Interfaces.
Pneumonia Drug Could Treat MRSA in Cystic Fibrosis
A new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.
Read More
13 Ways to Combat Multidrug Resistant Organisms and Ventilator-associated Pneumonia
Respiratory therapists play a crucial role in minimizing intubated patients’ risk of exposure to MDROs and VAP by following proper protocols solutions that help prevent infections.
Read More
New and Emerging Treatment Options for MDR Bacteria
In a video for MD Magazine, researchers talk in depth about current and developing agents for...
Read More
Smart Bacteria Help Each Other Survive
New research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron, Science Daily reports.
Read More
Cytokine IFN-γ Helps Clear Lethal Bacteria In Cystic Fibrosis
Boosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests.
Read More
Fighting Waterborne Pathogens To Protect Ventilated Patients
In addition to the constant threat of ventilator-associated pneumonia, ventilated patients also face dangers from other less common hospital-acquired infections, including waterborne pathogens that can occur during humidification.
Read More
Natural Antimicrobial Exacerbates Infection In Cystic Fibrosis
An antimicrobial peptide produced by human immune cells can promote mutations in P. aeruginosa bacterium, a common cause of death in cystic fibrosis patients.
Read MoreHow Bacteria Y-Pestis Overwhelms The Lungs To Cause Pneumonic Plague
When the bacterium Yersinia pestis enters the lungs, it causes pneumonic plague, a disease that is 100 percent fatal if untreated. The way in which Y. pestis evades the immune system and kills people in a matter of days has largely confounded scientists, until now.
Read More
Structure of MRSA Antibiotic-Resistant Protein Identified
Researchers uncovered the 3-D structure of the a protein that confers antibiotic resistance methicillin-resistant Staphylococcus aureus (MRSA). The find may allow researchers to develop an effective antibiotic against the bacterial superbug.
Read More
Doctors Without Borders: Tuberculosis Drug Development Needed
Researchers from Doctors Without Borders say a lack of candidate compounds is “cause for alarm,” given the global emergence of strains of tuberculosis that are resistant to current drugs.
Read More
Drug-Resistant Pathogens: Mechanisms of Resistance and Emerging Strains
Every year 160 million prescriptions for antibiotics are written in the United States, nearly 30 prescriptions per 100 persons. Probably half are inappropriate.
Read More